30442153|t|Ca2+-dependent endoplasmic reticulum stress correlation with astrogliosis involves upregulation of KCa3.1 and inhibition of AKT/mTOR signaling.
30442153|a|BACKGROUND: The intermediate-conductance Ca2+-activated K+ channel KCa3.1 was recently shown to control the phenotype switch of reactive astrogliosis (RA) in Alzheimer's disease (AD). METHODS: KCa3.1 channels expression and cell localization in the brains of AD patients and APP/PS1 mice model were measured by immunoblotting and immunostaining. APP/PS1 mice and KCa3.1-/-/APP/PS1 mice were subjected to Morris water maze test to evaluate the spatial memory deficits. Glia activation and neuron loss was measured by immunostaining. Fluo-4AM was used to measure cytosolic Ca2+ level in beta-amyloid (Abeta) induced reactive astrocytes in vitro. RESULTS: KCa3.1 expression was markedly associated with endoplasmic reticulum (ER) stress and unfolded protein response (UPR) in both Abeta-stimulated primary astrocytes and brain lysates of AD patients and APP/PS1 AD mice. The KCa3.1 channel was shown to regulate store-operated Ca2+ entry (SOCE) through an interaction with the Ca2+ channel Orai1 in primary astrocytes. Gene deletion or pharmacological blockade of KCa3.1 protected against SOCE-induced Ca2+ overload and ER stress via the protein kinase B (AKT) signaling pathway in astrocytes. Importantly, gene deletion or blockade of KCa3.1 restored AKT/mechanistic target of rapamycin signaling both in vivo and in vitro. Consistent with these in vitro data, expression levels of the ER stress markers 78-kDa glucose-regulated protein and CCAAT/enhancer-binding protein homologous protein, as well as that of the RA marker glial fibrillary acidic protein were increased in APP/PS1 AD mouse model. Elimination of KCa3.1 in KCa3.1-/-/APP/PS1 mice corrected these abnormal responses. Moreover, glial activation and neuroinflammation were attenuated in the hippocampi of KCa3.1-/-/APP/PS1 mice, as compared with APP/PS1 mice. In addition, memory deficits and neuronal loss in APP/PS1 mice were reversed in KCa3.1-/-/APP/PS1 mice. CONCLUSIONS: Overall, these results suggest that KCa3.1 is involved in the regulation of Ca2+ homeostasis in astrocytes and attenuation of the UPR and ER stress, thus contributing to memory deficits and neuronal loss.
30442153	0	4	Ca2+	ChemicalEntity	D002118
30442153	61	73	astrogliosis	DiseaseOrPhenotypicFeature	D005911
30442153	99	105	KCa3.1	GeneOrGeneProduct	16534,3783
30442153	124	127	AKT	GeneOrGeneProduct	11651,207
30442153	128	132	mTOR	GeneOrGeneProduct	2475,56717
30442153	160	210	intermediate-conductance Ca2+-activated K+ channel	GeneOrGeneProduct	16534,3783
30442153	211	217	KCa3.1	GeneOrGeneProduct	16534
30442153	272	293	reactive astrogliosis	DiseaseOrPhenotypicFeature	D005911
30442153	295	297	RA	DiseaseOrPhenotypicFeature	D005911
30442153	302	321	Alzheimer's disease	DiseaseOrPhenotypicFeature	D000544
30442153	323	325	AD	DiseaseOrPhenotypicFeature	D000544
30442153	337	343	KCa3.1	GeneOrGeneProduct	16534,3783
30442153	403	405	AD	DiseaseOrPhenotypicFeature	D000544
30442153	406	414	patients	OrganismTaxon	9606
30442153	419	422	APP	GeneOrGeneProduct	11820,351
30442153	423	426	PS1	GeneOrGeneProduct	5663
30442153	427	431	mice	OrganismTaxon	10090
30442153	490	493	APP	GeneOrGeneProduct	11820,351
30442153	494	497	PS1	GeneOrGeneProduct	5663
30442153	498	502	mice	OrganismTaxon	10090
30442153	507	513	KCa3.1	GeneOrGeneProduct	16534
30442153	517	520	APP	GeneOrGeneProduct	11820,351
30442153	521	524	PS1	GeneOrGeneProduct	5663
30442153	525	529	mice	OrganismTaxon	10090
30442153	595	610	memory deficits	DiseaseOrPhenotypicFeature	D008569
30442153	632	643	neuron loss	DiseaseOrPhenotypicFeature	D009422
30442153	676	684	Fluo-4AM	ChemicalEntity	C409648
30442153	715	719	Ca2+	ChemicalEntity	D000069285
30442153	729	741	beta-amyloid	GeneOrGeneProduct	351
30442153	743	748	Abeta	GeneOrGeneProduct	351
30442153	797	803	KCa3.1	GeneOrGeneProduct	16534,3783
30442153	922	927	Abeta	GeneOrGeneProduct	11820,351
30442153	979	981	AD	DiseaseOrPhenotypicFeature	D000544
30442153	982	990	patients	OrganismTaxon	9606
30442153	995	998	APP	GeneOrGeneProduct	11820,351
30442153	999	1002	PS1	GeneOrGeneProduct	5663
30442153	1003	1005	AD	DiseaseOrPhenotypicFeature	D000544
30442153	1006	1010	mice	OrganismTaxon	10090
30442153	1016	1022	KCa3.1	GeneOrGeneProduct	16534
30442153	1068	1072	Ca2+	ChemicalEntity	D000069285
30442153	1118	1122	Ca2+	ChemicalEntity	D002118
30442153	1131	1136	Orai1	GeneOrGeneProduct	109305
30442153	1205	1211	KCa3.1	GeneOrGeneProduct	16534
30442153	1243	1247	Ca2+	ChemicalEntity	D000069285
30442153	1279	1295	protein kinase B	GeneOrGeneProduct	11651
30442153	1297	1300	AKT	GeneOrGeneProduct	11651
30442153	1377	1383	KCa3.1	GeneOrGeneProduct	16534
30442153	1393	1396	AKT	GeneOrGeneProduct	11651
30442153	1397	1428	mechanistic target of rapamycin	GeneOrGeneProduct	56717
30442153	1546	1578	78-kDa glucose-regulated protein	GeneOrGeneProduct	14828
30442153	1583	1632	CCAAT/enhancer-binding protein homologous protein	GeneOrGeneProduct	13198
30442153	1657	1659	RA	DiseaseOrPhenotypicFeature	D005911
30442153	1667	1698	glial fibrillary acidic protein	GeneOrGeneProduct	14580
30442153	1717	1720	APP	GeneOrGeneProduct	11820,351
30442153	1721	1724	PS1	GeneOrGeneProduct	5663
30442153	1725	1727	AD	DiseaseOrPhenotypicFeature	D000544
30442153	1728	1733	mouse	OrganismTaxon	10090
30442153	1756	1762	KCa3.1	GeneOrGeneProduct	16534
30442153	1766	1772	KCa3.1	GeneOrGeneProduct	16534
30442153	1776	1779	APP	GeneOrGeneProduct	11820,351
30442153	1780	1783	PS1	GeneOrGeneProduct	5663
30442153	1784	1788	mice	OrganismTaxon	10090
30442153	1856	1873	neuroinflammation	DiseaseOrPhenotypicFeature	D007249
30442153	1911	1917	KCa3.1	GeneOrGeneProduct	16534
30442153	1921	1924	APP	GeneOrGeneProduct	11820,351
30442153	1925	1928	PS1	GeneOrGeneProduct	5663
30442153	1929	1933	mice	OrganismTaxon	10090
30442153	1952	1955	APP	GeneOrGeneProduct	11820,351
30442153	1956	1959	PS1	GeneOrGeneProduct	5663
30442153	1960	1964	mice	OrganismTaxon	10090
30442153	1979	1994	memory deficits	DiseaseOrPhenotypicFeature	D008569
30442153	1999	2012	neuronal loss	DiseaseOrPhenotypicFeature	D009422
30442153	2016	2019	APP	GeneOrGeneProduct	11820,351
30442153	2020	2023	PS1	GeneOrGeneProduct	5663
30442153	2024	2028	mice	OrganismTaxon	10090
30442153	2046	2052	KCa3.1	GeneOrGeneProduct	16534
30442153	2056	2059	APP	GeneOrGeneProduct	11820,351
30442153	2060	2063	PS1	GeneOrGeneProduct	5663
30442153	2064	2068	mice	OrganismTaxon	10090
30442153	2119	2125	KCa3.1	GeneOrGeneProduct	16534,3783
30442153	2159	2163	Ca2+	ChemicalEntity	D000069285
30442153	2253	2268	memory deficits	DiseaseOrPhenotypicFeature	D008569
30442153	2273	2286	neuronal loss	DiseaseOrPhenotypicFeature	D009422
30442153	Association	14580	D000544	Novel
30442153	Association	109305	16534	Novel
30442153	Association	D009422	D000069285	Novel
30442153	Association	D009422	5663	No
30442153	Association	D009422	351	No
30442153	Association	D009422	11820	No
30442153	Association	D009422	16534	Novel
30442153	Association	D000069285	351	Novel
30442153	Association	D000069285	D008569	Novel
30442153	Association	5663	D008569	No
30442153	Association	351	D008569	No
30442153	Association	11820	D008569	No
30442153	Association	D005911	14580	No
30442153	Association	56717	D005911	Novel
30442153	Association	2475	D005911	Novel
30442153	Association	207	D005911	Novel
30442153	Association	11651	D005911	Novel
30442153	Association	3783	D000544	No
30442153	Association	3783	D009422	Novel
30442153	Association	3783	D008569	Novel
30442153	Association	3783	D005911	Novel
30442153	Association	16534	D000544	No
30442153	Negative_Correlation	16534	14580	Novel
30442153	Negative_Correlation	16534	13198	Novel
30442153	Negative_Correlation	16534	14828	Novel
30442153	Association	16534	D000069285	Novel
30442153	Association	16534	D008569	Novel
30442153	Association	16534	D005911	Novel
30442153	Negative_Correlation	16534	56717	Novel
30442153	Negative_Correlation	16534	11651	Novel
30442153	Association	D002118	109305	No
30442153	Association	D002118	D005911	Novel
30442153	Association	D002118	56717	Novel
30442153	Association	D002118	2475	Novel
30442153	Association	D002118	207	Novel
30442153	Association	D002118	11651	Novel
30442153	Association	D002118	3783	Novel
30442153	Association	D002118	16534	Novel